Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovodak treatment response in chronic hepatitis C
IRCT201702016388N7Phase 2Completed
- Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sofosbuvir + daclatasvir in hepatitis C virus infection (2 arms), sponsored by Research Deputy of Tabriz University of Medical Sciences. Started Nov 2016; status: completed.
02
Drugs
sofosbuvir + daclatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on IRCT201702016388N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201702016388N7.